23rd Annual Market Access Summit 2024 | Market Access Canada | 16 October 2024 | TBA, Toronto, Canada

This Summit returns with industry experts to help you navigate a new pharma market environment. This year is proving to be a pivotal year in pharma market.

• Understand how Health Canada’s new National Strategy for Rare Diseases is unfolding.
• Gain valuable insight on how prepared Canada is for the new wave of treatments on the horizon.
• Discover how the increased substitution of biosimilars and the new generic agreement will impact the pharma marketplace.
• Realize the transformative impact that greater collaboration on gathering and sharing real-world evidence (RWE) is having on market access.
• Determine how Patient Support Programs (PSPs) need to evolve to ensure patients have access to the new treatments they require.

This Summit will comprise of in-person sessions boasting interactive discussions, a range of breakout sessions delving into the current industry opportunities and challenges and invaluable face-to-face networking opportunities.

2023 Past Speakers

André Picard
Author, Journalist, Health Reporter and Columnist, The Globe and Mail

Daniel MacDonald
Director General, Drugs for Rare Diseases, Health Canada

Sylvie Bouchard
Director, Drug Evaluation and Technology Assessment for Reimbursement, INESSS

Amanda Allard, Director
Director, Pharmaceutical Reviews, CADTH

Ned Pojskic
Vice President, Pharmacy Benefits Management, GreenShield Canada